drugset / Trial / NCT00582725
R-CHOP + GM-CSF for Previously Untreated LCL in Elderly
NaSingle-groupOpen-labelTreatment
Summary
Patients will receive 6 to 8 cycles of R-CHOP (Rituximab, Cyclophosphamide, doxorubicin, vincristine, and prednisone), with GM-CSF.
Timeline
- Start
- 2002-03
- Primary completion
- 2005-12
- Completion
- 2010-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cyclophosphamide | Other / unclassified | — | — |
| Subject | Doxorubicin | Other / unclassified | — | — |
| Subject | GM-CSF | Protein / enzyme biologic | — | — |
| Subject | Prednisone | Other / unclassified | — | — |
| Subject | Rituximab | Monoclonal antibody | — | — |
| Subject | Vincristine | Small molecule | — | — |